Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Cancers|April 3, 2021
Targeting the IL-6/STAT3 Signalling Cascade to Reverse Tamoxifen Resistance in Estrogen Receptor Positive Breast CancerHo Tsoi, Ellen P S Man, Ka Man Chau, et al.
International Journal of Molecular Sciences|December 11, 2022
Modulating the Activity of Androgen Receptor for Treating Breast CancerChan-Ping You, Ho Tsoi, Ellen P S Man, et al.
Cancers|March 10, 2022
Targeting Ribosome Biogenesis to Combat Tamoxifen Resistance in ER+ve Breast CancerHo Tsoi, Chan-Ping You, Man-Hong Leung, et al.
Life (Basel, Switzerland)|August 29, 2024
Correction: Tsoi et al. Overexpression of BQ323636.1 Modulated AR/IL-8/CXCR1 Axis to Confer Tamoxifen Resistance in ER-Positive Breast Cancer. Life 2022, 12, 93Ho Tsoi, Ling Shi, Man-Hong Leung, et al.
Life (Basel, Switzerland)|January 21, 2022
Overexpression of BQ323636.1 Modulated AR/IL-8/CXCR1 Axis to Confer Tamoxifen Resistance in ER-Positive Breast CancerHo Tsoi, Ling Shi, Man-Hong Leung, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 23, 2017
Dual-utility NLS drives RNF169-dependent DNA damage responsesLiwei An, Yiyang Jiang, Howin H W Ng, et al.
International Journal of Molecular Sciences|October 27, 2022
Checkpoint Kinase 2 Inhibition Can Reverse Tamoxifen Resistance in ER-Positive Breast CancerHo Tsoi, Wai-Chung Tsang, Ellen P S Man, et al.
Oncogene|February 19, 2020
Phosphorylation independent eIF4E translational reprogramming of selective mRNAs determines tamoxifen resistance in breast cancerChun Gong, Ho Tsoi, Ka Chun Mok, et al.
Cells|September 13, 2025
BQ323636.1 Employs the AR-CCRK Axis to Modulate the Expression of KU70 to Interfere with Non-Homologous End Joining Mediated DNA Repair MechanismHo Tsoi, Zi-Qing So, Ellen P S Man, et al.
Cancers|May 16, 2023
SRSF5 Regulates the Expression of BQ323636.1 to Modulate Tamoxifen Resistance in ER-Positive Breast CancerHo Tsoi, Nicholas Nok-Ching Fung, Ellen P S Man, et al.
Pageof 2